Company Directory > CRO > Aragen Life Sciences
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aragen Life Sciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Aragen Life Sciences is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that provides end-to-end solutions for the pharmaceutical, biotechnology, agrochemical, and animal health industries. The company supports clients from early-stage drug discovery through development and commercial manufacturing of small and large molecules. Formerly known as GVK Biosciences, the company rebranded to Aragen in 2021 to reflect its transformation into a comprehensive R&D and manufacturing partner. It operates a global network of research and manufacturing facilities across India and the United States, serving over 400 clients, including major global pharmaceutical companies.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:CRDMO (Contract Research, Development, and Manufacturing Organization)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$200M-$300M
Founded:2000
Ownership:private
Status:operating
FUNDING
Stage:Secondary Buyout
Total Raised:$100M
Investors:Quadria Capital Investment Management
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service provider, no internal pipeline)
Modalities:Small molecule, mAb, Biologics, HPAPI
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Aragen Bioscience (USA)
Key Partnerships:Azurity Pharmaceuticals (dedicated formulation development center)
COMPETITION
Position:Leader
Competitors:Syngene International, Evotec, WuXi AppTec, Charles River Laboratories
LEADERSHIP
Key Executives:
Manni Kantipudi - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aragen Life Sciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.